Antiproliferative Effects of Fluoxetine on Colon Cancer Cells and in a Colonic Carcinogen Mouse Model

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kannen, Vinicius ^a,b   Hintzsche, Henning ^b   Zanette, Dalila L ^a   Silva, Wilson A ^a   Garcia, Sérgio B ^a   Waaga Gasser, Ana Maria ^b   Stopper, Helga ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; FLUOXETINE; METHYLNITRONITROSOGUANIDINE; PROTEIN P27; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFICACY; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TREATMENT RESPONSE; VASCULARIZATION;

EID: 84870269178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050043     Document Type: Article

References (46)

1. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, et al. (2010) Colorectal cancer. Lancet 375: 1030-1047.
2. Jaiswal AS, Banerjee S, Aneja R, Sarkar FH, Ostrov DA, et al. (2011) DNA polymerase beta as a novel target for chemotherapeutic intervention of colorectal cancer. PLOS One 6: e16691.
3. Abbas A, Yang G, Fakih M, (2010) Management of anal cancer in 2010. Part 2: current treatment standards and future directions. Oncology (Williston Park) 24: 417-424.
4. Tutton PJ, Barkla DH, (1986) Serotonin receptors influencing cell proliferation in the jejunal crypt epithelium and in colonic adenocarcinomas. Anticancer Res 6: 1123-1126.
5. Kannen V, Marini T, Turatti A, Carvalho MC, Brandao ML, et al. (2011) Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats. Toxicol Lett 204: 134-140.
6. Koh SJ, Kim JM, Kim IK, Kim N, Jung HC, et al. (2011) Fluoxetine inhibits NF-{kappa}B signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice. Am J Physiol Gastrointest Liver Physiol 301(1): G9-19.
7. Muller JC, Imazaki PH, Boareto AC, Lourenco EL, Golin M, et al. (2012) In vivo and in vitro estrogenic activity of the antidepressant fluoxetine. Reprod Toxicol 34(1): 80-85.
8. Miguel C, Albuquerque E, (2011) Drug interaction in psycho-oncology: antidepressants and antineoplastics. Pharmacology 88: 333-339.
9. Frick LR, Palumbo ML, Zappia MP, Brocco MA, Cremaschi GA, et al. (2008) Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms. Biochem Pharmacol 75: 1817-1826.
10. Kubera M, Grygier B, Arteta B, Urbanska K, Basta-Kaim A, et al. (2009) Age-dependent stimulatory effect of desipramine and fluoxetine pretreatment on metastasis formation by B16F10 melanoma in male C57BL/6 mice. Pharmacol Rep 61: 1113-1126.
11. Kirkova M, Tzvetanova E, Vircheva S, Zamfirova R, Grygier B, et al. (2010) Antioxidant activity of fluoxetine: studies in mice melanoma model. Cell Biochem Funct 28: 497-502.
12. Jia L, Shang YY, Li YY, (2008) Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice. World J Gastroenterol 14: 4377-4382.
13. Coogan PF, (2006) Review of the epidemiological literature on antidepressant use and breast cancer risk. Expert Rev Neurother 6: 1363-1374.
14. Taketo MM, (2009) Role of bone marrow-derived cells in colon cancer: lessons from mouse model studies. J Gastroenterol 44: 93-102.
15. Park SW, Kim HS, Choi MS, Jeong WJ, Heo DS, et al. (2011) The effects of the stromal cell-derived cyclooxygenase-2 metabolite PGE2 on proliferation of colon cancer cells. J Pharmacol Exp Ther 336(2): 516-523.
16. Waldner MJ, Wirtz S, Jefremow A, Warntjen M, Neufert C, et al. (2010) VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer. J Exp Med 207: 2855-2868.
17. Kannen V, Marini T, Zanette DL, Frajacomo FT, Silva GE, et al. (2011) The melatonin action on stromal stem cells within pericryptal area in colon cancer model under constant light. Biochem Biophys Res Commun 405: 593-598.
18. Todaro M, Francipane MG, Medema JP, Stassi G, (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138: 2151-2162.
19. Wong WM, Mandir N, Goodlad RA, Wong BC, Garcia SB, et al. (2002) Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut 50: 212-217.
20. Stepulak A, Rzeski W, Sifringer M, Brocke K, Gratopp A, et al. (2008) Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells. Cancer Biol Ther 7: 1685-1693.
21. Tutton PJ, Barkla DH, (1982) Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br J Cancer 46: 260-265.
22. Maurin N, Forgue-Lafitte ME, Levy P, Zimber A, Bara J, (2007) Progression of tumors arising from large ACF is associated with the MUC5AC expression during rat colon MNNG carcinogenis. Int J Cancer 120: 477-483.
23. Garcia SB, Barros LT, Turatti A, Martinello F, Modiano P, et al. (2006) The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen. Cancer Lett 240: 221-224.
24. Schmid U, Stopper H, Heidland A, Schupp N, (2008) Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro. Diabetes Metab Res Rev 24: 371-377.
25. Meurette O, Lefeuvre-Orfila L, Rebillard A, Lagadic-Gossmann D, Dimanche-Boitrel MT, (2005) Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations. Clin Cancer Res 11: 3075-3083.
26. Paulsen JE, Loberg EM, Olstorn HB, Knutsen H, Steffensen IL, et al. (2005) Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Cancer Res 65: 121-129.
27. Mazucato VM, Silveira ESAM, Nicoletti LM, Jamur MC, Oliver C, (2011) GD1b-derived gangliosides modulate FcepsilonRI endocytosis in mast cells. J Histochem Cytochem 59: 428-440.
28. Liao Z, Boileau TW, Erdman JW Jr, Clinton SK, (2002) Interrelationships among angiogenesis, proliferation, and apoptosis in the tumor microenvironment during N-methyl-N-nitrosourea androgen-induced prostate carcinogenesis in rats. Carcinogenesis 23: 1701-1711.
29. Tammali R, Reddy AB, Srivastava SK, Ramana KV, (2011) Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo. Angiogenesis 14(2): 209-221.
30. Sovalat H, Scrofani M, Eidenschenk A, Pasquet S, Rimelen V, et al. (2011) Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells. Exp Hematol 39: 495-505.
31. Li H, Zimmerlin L, Marra KG, Donnenberg VS, Donnenberg AD, et al. (2011) Adipogenic Potential of Adipose Stem Cell Subpopulations. Plast Reconstr Surg 128(3): 663-672.
32. Kornhuber J, Reichel M, Tripal P, Groemer TW, Henkel AW, et al. (2009) The role of ceramide in major depressive disorder. Eur Arch Psychiatry Clin Neurosci 259 (Suppl 2):: S199-204.
33. Krishnan A, Hariharan R, Nair SA, Pillai MR, (2008) Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem Pharmacol 75: 1924-1934.
34. Zhang B, Wang X, Wang Y, (2009) Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG. J Exp Clin Cancer Res 28: 56.
35. Jaiswal AS, Multani AS, Pathak S, Narayan S, (2004) N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA. Mol Cancer 3: 3.
36. Cardoso JF, Cohen C, Jordao AA Jr, Vannucchi H, Garcia SB, et al. (2011) Light and moderate doses of ethanol in chemical carcinogenesis of the colon in rats. Nutr Cancer 63: 1029-1035.
37. Reshef R, Rozen P, Fireman Z, Fine N, Barzilai M, et al. (1990) Effect of a calcium-enriched diet on the colonic epithelial hyperproliferation induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats on a low calcium and fat diet. Cancer Res 50: 1764-1767.
38. Jiang XY, Qian LP, Zheng XJ, Xia YY, Jiang YB, et al. (2009) Interventional effect of Ginkgo biloba extract on the progression of gastric precancerous lesions in rats. J Dig Dis 10: 293-299.
39. Ngan BY, Forte V, Campisi P, (2008) Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy. Arch Otolaryngol Head Neck Surg 134: 1170-1176.
40. Hristov M, Erl W, Weber PC, (2003) Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23: 1185-1189.
41. Meregalli M, Farini A, Belicchi M, Torrente Y, (2010) CD133(+) cells isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Ther 10: 1521-1528.
42. Krause DS, Fackler MJ, Civin CI, May WS, (1996) CD34: structure, biology, and clinical utility. Blood 87: 1-13.
43. Ye C, Bai L, Yan ZQ, Wang YH, Jiang ZL, (2008) Shear stress and vascular smooth muscle cells promote endothelial differentiation of endothelial progenitor cells via activation of Akt. Clin Biomech (Bristol, Avon) 23 (Suppl 1):: S118-124.
44. McDonald SA, Preston SL, Lovell MJ, Wright NA, Jankowski JA, (2006) Mechanisms of disease: from stem cells to colorectal cancer. Nat Clin Pract Gastroenterol Hepatol 3: 267-274.
45. Kallifatidis G, Rausch V, Baumann B, Apel A, Beckermann BM, et al. (2009) Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 58: 949-963.
46. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, et al. (2011) Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo. FASEB J 25(6): 2022-2030.